Powered by Google-Search & Google-Books Chinese Standards Shop Database: 169760 (Aug 8, 2020)
HOME  COVID-19   Quotation   Tax   Examples Standard-List   Contact-Us   View-Cart
  

YY/T 0887-2013

Chinese Standard: 'YY/T 0887-2013'
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusRelated Standard
YY/T 0887-2013English339 Add to Cart Days<=3 Radioactive seeds implantation treatment planning system. Requirements for dose calculations and test methods Valid YY/T 0887-2013
YY/T 0887-2013Chinese17 Add to Cart <=1-day [PDF from Chinese Authority, or Standard Committee, or Publishing House]

   

BASIC DATA
Standard ID YY/T 0887-2013 (YY/T0887-2013)
Description (Translated English) Radioactive seeds implantation treatment planning system. Requirements for dose calculations and test methods
Sector / Industry Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard C43
Classification of International Standard 11.040.60
Word Count Estimation 17,196
Quoted Standard GB/T 17857
Drafting Organization Beijing Medical Device Testing
Administrative Organization The standards set by the National Technical Committee of Standardization for medical appliances radiotherapy, nuclear medicine science equipment Technical Committee and radiation dose
Regulation (derived from) State Food and Drug Administration Notice No. 36 of 2013; industry standard for filing Notice 2013 No. 12 (No. 168 overall)
Proposing organization State Food and Drug Administration
Issuing agency(ies) State Food and Drug Administration
Summary This standard specifies: radioactive seed implant treatment planning system for tablets (hereinafter referred to as treatment planning systems) Requirements and test methods for dose calculation. This standard applies to: radioactive seed implant treatmen

YY/T 0887-2013
Radioactive seeds implantation treatment planning system.Requirements for dose calculations and test methods
ICS 11.040.60
C43
People's Republic of China pharmaceutical industry standards
Radioactive seed implant treatment planning system Reap
Requirements and test methods for dose calculation
Issued on. 2013-10-21
2014-10-01 implementation
China Food and Drug Administration released
Foreword
This standard was drafted in accordance with GB/T 1.1-2009 given rules.
Please note that some of the content of this standard may involve patents. The standard release mechanism does not assume the responsibility to identify these patents.
This standard was proposed by the China Food and Drug Administration.
This standard by the National Standardization Technical Committee appliances medical radiotherapy, nuclear medicine science equipment at the Technical Committee and the radiation dose
(SAC/TC10/SC3) centralized.
This standard was drafted. Beijing Medical Device Control, Beijing University of Aeronautics and Astronautics, Shandong Xinhua Medical Instrument shares have
Ltd., Shenzhen City Haibo Technology Co., Ltd.
The main drafters of this standard. Feng Jian, Zhou Fu roots, Zhaoliang Dong, Choi Chi.
Radioactive seed implant treatment planning system Reap
Requirements and test methods for dose calculation
1 Scope
This standard specifies the radioactive seed implant treatment planning system particle (hereinafter referred to treatment planning system) dose calculation requirements and tests
method.
This standard applies to radioactive seed implantation dose tablets treatment planning system calculations.
2 Normative references
The following documents for the application of this document is essential. For dated references, only the dated version suitable for use herein
Member. For undated references, the latest edition (including any amendments) applies to this document.
GB/T 17857 Medical imaging academic language (radiotherapy, nuclear medicine and radiation dosimetry equipment)
3 Terms and Definitions
GB/T 17857 and defined by the following terms and definitions apply to this document.
3.1
Radioactive seed grain radioactiveseeds
Implants for clinical treatment, according to certain requirements encapsulated radionuclides. Common useful titanium tube symmetrical package 103Pd 125I and the like.
3.2
Radioactive seed implant therapy tablets radioactiveseedsimplantationtherapy
By percutaneous or other means radioactive seeds into the body grain implementation of treatment approach.
If you do not remove the implantation of grain seeds, also known as permanent radioactive seed implantation therapy tablets.
4 Requirements
4.1 length deviation reconstruction
The length of the treatment planning system reconstruction deviation is not more than 2mm.
4.2 Volume Reconstruction deviation
Treatment planning system of the reconstructed volume deviation is less than 10%.
4.3 dose calculation error
Dose treatment planning system to calculate the deviation between the theoretical value of not more than 10%.
4.4 accuracy of dose distributions
The accuracy of dose distributions for the treatment planning system is not less than 90%.
Related standard:   YY/T 0888-2013  YY/T 0889-2013
Related PDF sample:   YY/T 0889-2013  YY/T 0888-2013
   
 
Privacy   ···   Product Quality   ···   About Us   ···   Refund Policy   ···   Fair Trading   ···   Quick Response
Field Test Asia Limited | Taxed in Singapore: 201302277C | Copyright 2012-2020